Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Abbott Laboratories (ABT) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 56,654,488
  • Shares Outstanding, K 1,470,000
  • Annual Sales, $ 20,405 M
  • Annual Income, $ 4,423 M
  • 36-Month Beta 0.92
  • Price/Sales 2.78
  • Price/Book 2.71

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.38 +3.48%
on 12/01/16
41.53 -6.86%
on 11/09/16
-1.15 (-2.89%)
since 11/08/16
3-Month
37.38 +3.48%
on 12/01/16
43.78 -11.65%
on 10/10/16
-3.17 (-7.57%)
since 09/08/16
52-Week
36.00 +7.44%
on 01/28/16
46.22 -16.31%
on 12/17/15
-6.87 (-15.08%)
since 12/08/15

Most Recent Stories

More News
Mylan (MYL) Stock Falls on Restructuring Plans, Layoffs

Mylan (MYL) has revealed restructuring programs in certain locations in an attempt to streamline its operations globally as it focuses on integrating acquisitions.

Asian stocks advance ahead of ECB decision

SEOUL, South Korea (AP) — Asian shares rose on Thursday after an overnight surge on U.S. markets. Investors were focused the European Central Bank's meeting later in the day.

Abbott seeks to end buyout deal for Alere

NEW YORK (AP) — Abbott is seeking to terminate its buyout of troubled medical diagnostics maker Alere as that company deals with the fallout of a key device recall and government investigations.

New Collaborations and Licensing Activities for Biotech/Pharma Industries Pick Up Pace Heading into 2017

Biotech and Big Pharma companies focus on forging ahead with developing pipeline candidates and licensing opportunities that appear to bea promising opportunity versus developing therapy products from...

Study: Hospital Nutrition Program Shortens Patient Stays and Reduces Readmissions

While proper nutrition is vital to staying healthy, its importance becomes more critical for patients recovering in the hospital. A new study by Advocate Health Care and Abbott (NYSE: ABT) found that...

Research and Markets - Biobanking Technologies - Expected to Reach $240.2 Billion in 2021 - Key Vendors are Novartis, Pfizer & Abbott Laboratories

DUBLIN, Dec 5, 2016 /PRNewswire/ --

Research and Markets - Biobanking Technologies - Expected to Reach $240.2 Billion in 2021 - Key Vendors are Novartis, Pfizer & Abbott Laboratories

Research and Markets has announced the addition of the "Biobanking: Technologies and Global Markets" report to their offering.

MedTech Sails Through Macro Woes: Stocks in Focus

MedTech Sails Through Macro Woes: Stocks in Focus

Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform

Abbott (NYSE: ABT) announced today its i-STAT® Alinity(TM) System, an innovative, handheld blood testing platform, received CE Mark and is now for sale in Europe and other countries that recognize CE...

Digestion Aids (Prebiotics, Probiotics and Digestive enzymes) Market 2016-2021: Key Players are Nebraska Cultures, Chr. Hansen,Yakult Honsha, Abbott Laboratories & Dabur India - Research and Markets

Research and Markets has announced the addition of the "Digestion Aids Market: By Product Type (Prebiotics, Probiotics and Digestive enzymes), By Geography (Europe, Asia Pacific, North America,...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Support & Resistance

2nd Resistance Point 39.27
1st Resistance Point 38.98
Last Price 38.68
1st Support Level 38.20
2nd Support Level 37.71

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.